generics

Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing
Forbes
Mon, 01/2/23 - 06:28 pm
Mark Cuban
generics
drug pricing
Mark Cuban Cost Plus Drugs
Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors
Endpoints
Sun, 12/11/22 - 01:29 pm
Lupin
generics
regulatory
FDA
inspections
FDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial
Endpoints
Sat, 11/26/22 - 07:15 pm
Sarepta Therapeutics
generics
Duchenne Muscular Dystrophy
FDA
eteplirsen
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says
Fierce Pharma
Wed, 11/23/22 - 07:33 am
Bristol Myers Squibb
Celgene
Revlimid
patents
generics
FDA sees room for growth for complex generics
RAPS.org
Mon, 11/14/22 - 07:07 pm
generics
complex generics
regulagtory
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
Mon, 10/31/22 - 04:22 pm
AbbVie
Orilissa
generics
Sandoz
Teva Pharmaceuticals
endometriosis
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Thu, 10/27/22 - 11:04 am
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
Takeda sues Apotex over prospective generic versions of its top leukemia drug
Endpoints
Thu, 10/20/22 - 11:33 pm
Takeda
Iclusig
generics
Apotex
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
CP WIre
Thu, 10/20/22 - 12:21 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Thu, 10/20/22 - 12:27 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Fri, 10/14/22 - 10:40 am
Novartis
Gilenya
generics
Supreme Court
MS
multiple sclerosis
FDA updates guidances to clarify new generic drug meeting requirements in GDUFA III
RAPS.org
Thu, 10/6/22 - 10:49 am
regulatory
FDA
generics
GDUFA
Generics, biosimilars saved the healthcare system $373B in 2021
Medical Marketing and Media
Sun, 10/2/22 - 07:43 pm
generics
biosimilars
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
Wed, 09/28/22 - 11:38 am
generics
Europe
Teva Pharmaceutical
Sandoz
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Endpoints
Thu, 09/22/22 - 11:12 pm
Merck
Januvia
Janumet
generics
legal
Viatris
Califf: FDA committed to boosting complex generic drug development
RAPS.org
Wed, 09/21/22 - 10:23 am
Robert Califf
FDA
generics
drug development
Over $50M in federal funds are going to Virginia’s pharma manufacturing sector
Endpoints
Tue, 09/6/22 - 05:09 pm
Virginia
federal government
generics
drug manufacturing
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Novartis
drug manufacturing
Sandoz
generics
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
spinoffs
Novartis
Sandoz
generics
Indivior fails to escape class action lawsuit in Suboxone case
Endpoints
Tue, 08/23/22 - 10:25 pm
Indivior
legal
Suboxone
generics
opioids
opioid addiction

Pages